9 results for "Lin-Feng Guo"
Showing 1–9 · 1.16 seconds · RSS
-
Journal Article
Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy
Abstract Purpose To analyze outcomes and evaluate the survival benefits of metronomic chemotherapy (MC) with S-1 in locoregionally advanced nasopharyngeal carcinoma (LANPC) patients with residual EBV-DNA after induction chemotherapy (IC). Methods We retrospectively included patients diagnosed with…
-
Journal Article
The current role of immunotherapy in treating nasopharyngeal carcinoma
Immunotherapy has emerged as a cornerstone in the management of both recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) and locoregionally advanced NPC (LANPC). Evidence indicates that programmed death-1/programmed death ligand-1 (PD-1/PD-L1) inhibitors, whether administered as monotherapy or…
-
Journal Article
Real-world treatment practices and survival outcomes of patients with de novo metastatic nasopharyngeal carcinoma after chemoimmunotherapy
Abstract Objective To evaluate the real-world treatment practices and survival outcomes of patients with de novo metastatic nasopharyngeal carcinoma (dnMNPC) after the combination of programmed death-1(PD-1) inhibitors with chemotherapy. Methods We retrospectively gathered data from patients with…
-
Journal Article
Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
Abstract Purpose To investigate the optimal cycles of induction chemotherapy (IC) in patients with locoregionally advanced nasopharyngeal carcinoma (LANPC). Methods We included LANPC patients treated with two or three IC cycles from January 2015 to December 2021. The chi-square test, Kaplan-Meier…
-
Journal Article
The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy
Abstract Objective To investigate the impact of response to induction chemotherapy (IC) on survival outcomes in patients with locally advanced nasopharyngeal carcinoma (LANPC) and evaluate the efficacy of adding nimotuzumab to concurrent chemoradiotherapy (CCRT) based on different responses to IC…
-
Journal Article
Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer
Purpose To investigate the relationship between time to treatment initiation (TTI) of definitive radiotherapy and survival outcomes in locally advanced head and neck cancers (LAHNC). Methods We retrospectively included patients diagnosed between 2005 and 2015 from the Surveillance, Epidemiology…
-
Journal Article
Patterns of failure and prognosis in nasopharyngeal carcinoma according to Epstein-Barr virus DNA status
Abstract Purpose To investigate the patterns of failure and prognosis in recurrent or metastatic nasopharyngeal carcinoma (rmNPC) according to Epstein-Barr virus-DNA (EBV-DNA) status. Methods We included NPC patients who were diagnosed with locoregional recurrence (LRR) and/(or) distant metastasis…
-
Journal Article
Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas
Background To investigate the prognostic implications of histology among nasopharyngeal carcinoma (NPC) using the data from a Chinese cohort and the Surveillance, Epidemiology, and End Results (SEER) database.Methods We included patients diagnosed with WHO II and III subtypes NPC from two…
-
Journal Article
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma
Abstract Purpose To explore the failure patterns, outcomes, and treatment response of differentiated non-keratinizing nasopharyngeal carcinoma (DNKC) and to further investigate the role of plasma Epstein-Barr virus (EBV)-DNA in follow-up monitoring, prognostic prediction, and assessment of…